Mesoblast Quote - MSB

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

1.805

Bid

1.78

Offer

1.805

Volume

4,018,872

1.77 Day's Range 1.86

0.88 52 Week Range 3.37

Market Cap

1.33B

Previous Close

1.855

Open

1.84

Last Trade

185

1.795

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

6,180,157

Shares Outstanding

736,578,315

Dividend Yield

PE Ratio

-15.08

Earnings Per Share (EPS)

-0.12

Revenue

9.25M

Net Profit

-87.96M

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

www.mesoblast.com

Headquarters

Melbourne, Victoria, Aus

Founded

Mesoblast Limited is listed in the Biological Pds,ex Diagnstics sector of the Australian Stock Exchange with ticker MSB. The last closing price for Mesoblast was AUD1.86. Over the last year, Mesoblast shares have traded in a share price range of AUD 0.88 to AUD 3.37.

Mesoblast currently has 736,578,315 shares in issue. The market capitalisation of Mesoblast is AUD1.37 billion. Mesoblast has a price to earnings ratio (PE ratio) of -15.08.

Mesoblast Gets FDA's Special Pediatric Designation for Revascor Heart Treatment

By Dean Seal Mesoblast said regulators have granted their rare pediatric disease designation to its cell therapy Revascor for children with...

Mesoblast ADSs Plunge Premarket on Latest FDA Rejection

By Colin Kellaher American depositary shares of Mesoblast plummeted more than 65% in premarket trading Friday after the biopharmaceutical...

FDA Schedules Pre-License Inspection of Remestemcel-L Manufacturing

Biologics License Application (BLA) Resubmission for Pediatric Acute Graft-Versus-Host Disease (SR-aGVHD...

Mesoblast ADSs Rally as FDA Accepts Remestemcel-L Resubmission

By Colin Kellaher American depositary shares of Mesoblast Ltd. jumped more than 15% in early trading Wednesday after the biopharmaceutical company...

Mesoblast Shares Rise 11% After Resubmitting Biologics License Application

By Chris Wack Mesoblast Ltd. shares were up 11% to $3.67 Wednesday after the company said it resubmitted a biologics license application to the...

Mesoblast Shares Rise 10% After New Info Submitted to FDA for Remestemcel-L

By Chris Wack Mesoblast Ltd. shares were up 10% to $2.80 after the company said it submitted substantial new information to the U.S. Food and Drug...

Mesoblast to Hold Type C Meeting With FDA for Back Pain Treatment

By Chris Wack Mesoblast Ltd. said it has filed a request and expects to hold a Type C meeting with the U.S. Food & Drug Administration during...

Mesoblast Up 25% After Hours on Collaboration With Novartis

By Josh Beckerman Mesoblast Ltd. American depositary receipts surged 25% to $14.70 after hours as the company entered an exclusive worldwide...

Mesoblast Named Global Technology Leader in Cell Therapy Industry

Mesoblast Limited has been named by Frost & Sullivan as the 2017 Global Technology Leader in the Cell Therapy Industry. Mesoblast is...

Mesoblast’s Japan Licensee Receives Pricing for TEMCELL® HS Inj. for Treatment of Acute Graft Versus Host Disease

MELBOURNE, Australia and NEW YORK, Nov. 27, 2015 (GLOBE NEWSWIRE) -- Mesoblast Limited (ASX:MSB) (Nasdaq:MESO) today announced that its...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.045	2.55681818182	1.76	1.93	1.725	3617207	1.80547825	DE
4	-0.035	-1.90217391304	1.84	1.93	1.5725	5705635	1.71535147	DE
12	-0.315	-14.858490566	2.12	2.3	1.515	6180157	1.79421294	DE
26	0.205	12.8125	1.6	3.37	1.515	7376457	2.30526442	DE
52	0.735	68.691588785	1.07	3.37	0.88	6359901	1.8330551	DE
156	1.065	143.918918919	0.74	3.37	0.255	4762231	1.20957978	DE
260	-1.925	-51.6085790885	3.73	5.7	0.255	4618663	1.8920714	DE

MSB - Frequently Asked Questions (FAQ)

What is the current Mesoblast share price?

The current share price of Mesoblast is AUD 1.805

How many Mesoblast shares are in issue?

Mesoblast has 736,578,315 shares in issue

What is the market cap of Mesoblast?

The market capitalisation of Mesoblast is AUD 1.37B

What is the 1 year trading range for Mesoblast share price?

Mesoblast has traded in the range of AUD 0.88 to AUD 3.37 during the past year

What is the PE ratio of Mesoblast?

The price to earnings ratio of Mesoblast is -15.08

What is the cash to sales ratio of Mesoblast?

The cash to sales ratio of Mesoblast is 142.86

What is the reporting currency for Mesoblast?

Mesoblast reports financial results in USD

What is the latest annual turnover for Mesoblast?

The latest annual turnover of Mesoblast is USD 9.25M

What is the latest annual profit for Mesoblast?

The latest annual profit of Mesoblast is USD -87.96M

What is the registered address of Mesoblast?

The registered address for Mesoblast is LEVEL 38, 55 COLLINS STREET, MELBOURNE, VICTORIA, 3000

What is the Mesoblast website address?

The website address for Mesoblast is www.mesoblast.com

Which industry sector does Mesoblast operate in?

Mesoblast operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
OSLOncosil Medical Ltd	AUD 0.92 (30,566.67%)	10.07k
OSLOCOncoSil Medical Ltd	AUD 0.095 (9,400.00%)	9.94k
TALTalius Group Ltd	AUD 0.062 (675.00%)	50k
TM1OTerra Metals Ltd	AUD 0.018 (157.14%)	50k
HTMOHighTech Metals Ltd	AUD 0.02 (81.82%)	12.5k
JLLOJindalee Lithium Ltd	AUD 0.04 (-55.56%)	5k
VMLVital Metals Limited	AUD 0.002 (-33.33%)	6.78M
AXPAXP Energy Limited	AUD 0.001 (-33.33%)	50k
AOKAustralian Oil Company Ltd	AUD 0.002 (-33.33%)	15k
PIMOPinnacle Minerals Ltd	AUD 0.002 (-33.33%)	37.5k
OB1Orbminco Ltd	AUD 0.001 (0.00%)	106.9M
NMGNew Murchison Gold Ltd	AUD 0.019 (8.57%)	99.66M
DTRDateline resources Ltd	AUD 0.091 (-9.00%)	81.46M
VAUVault Minerals Ltd	AUD 0.44 (2.33%)	72.84M
RMLResolution Minerals Ltd	AUD 0.034 (0.00%)	69.05M